Ethics and Market related Issues in Deploying TACTs in Africa

Not Applicable

Active, not recruiting

• Conditions: Malaria; based combination therapies, Malaria, artemisinin, parasites resistant, artemisinin- Triple Artemisinin- based Combination Therapies

• Registration Number: TCTR20200204005
• Lead Sponsor: niversity of Oxford

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-04
• Study Completion: 2021-10-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 123

Inclusion Criteria

Male or Female, aged 18 years or above.

Participant is willing and able to give informed consent for participation in the study.

Exclusion Criteria

Have been identified with intellectual and/or cognitive disability which may affect his/her ability to comprehend the information about the project.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
An ethical framework for deploying TACTs in Africa 36 months from date of ethics approval Interview and focus group discussion

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A